Solution Structure of the DNA Binding Domain of HIV-1 Integrase
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The solution structure of the DNA binding domain of HIV-1 integrase (residues 220-270) has been determined by multidimensional NMR spectroscopy. The protein is a dimer in solution, and each subunit is composed of a five-stranded beta-barrel with a topology very similar to that of the SH3 domain. The dimer is formed by a stacked beta-interface comprising strands 2, 3, and 4, with the two triple-stranded antiparallel beta-sheets, one from each subunit, oriented antiparallel to each other. One surface of the dimer, bounded by the loop between strands beta 1 and beta 2, forms a saddle-shaped groove with dimensions of approximately 24 x 23 x 12 A in cross section. Lys264, which has been shown from mutational data to be involved in DNA binding, protrudes from this surface, implicating the saddle-shaped groove as the potential DNA binding site.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expansion of the intasome architecture in these viruses is dictated by three factors.”
From Structure and function of retroviral integrase (2022) · cites this paper as [44]
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 1×
“Eighty-two percent of the residues lie within the most favored region of the Ramachandran $,q plot, 16% in the additionally allowed regions, and 2% in the generously allowed regions (Laskowski et al., 1993).”
BackgroundCHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
Solvation energy in protein folding and binding
Eisenberg, D., & McLachlan, A. D. (1986) · Nature · doi:10.1038/319199a0 · Cited by 1,863
Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“The catalytic domain is also dimeric with the two subunits oriented parallel to each other (Dyda et al., 1994).”
BackgroundSelf-citationNilges, M., Clore, G. M., & Gronenborn, A. M. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81148-7 · Cited by 770 · cited 1×
“The structures were calculated using a modified version of the hybrid distance geometry-dynamical simulated annealing protocol (Nilges et al., 1988 square-well quadratic potentials for the experimental distance and torsion angle restraints, and a quartic van der Waals repulsion term for the…”
MethodSelf-citationProtein Design by Binary Patterning of Polar and Nonpolar Amino Acids
Kamtekar, S., Schiffer, J. M., Xiong, H., Babik, J. M., & Hecht, M. H. (1993) · Science · doi:10.1126/science.8259512 · Cited by 730
Protein-protein interactions: A review of protein dimer structures
Jones, S., & Thornton, J. M. (1995) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(94)00008-w · Cited by 562
Binding and Stimulation of HIV-1 Integrase by a Human Homolog of Yeast Transcription Factor SNF5
Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R., & Goff, S. P. (1994) · Science · doi:10.1126/science.7801128 · Cited by 530 · cited 1×
“The Val260 -Glu mutation affects multimeric interactions in intact integrase (Kalpana et al., 1994).”
BackgroundStructure of papain refined at 1.65 Å resolution
Kamphuis, I. G., Kalk, K. H., Swarte, M. B. A., & Drenth, J. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90467-4 · Cited by 518 · cited 1×
“These include the . carboxy-terminal domains of papain (Kamphuis et al., 1984) and the BirA repressor (Wilson et al., 1992), type I1 plasmid-encoded R67 dihydrofolate reductase (Matthews et al., 1986), the PsaE polypeptide from photosystem I of cyanobacteria (Falzone et al., 1994), and the small…”
BackgroundRibbon models of macromolecules
Carson, M. (1987) · Journal of Molecular Graphics · doi:10.1016/0263-7855(87)80010-3 · Cited by 516 · cited 2×
“The figure was generated with the program RIBBONS (Carson, 1987).”
Method
Cited by
HIV-1: Fifteen Proteins and an RNA
Frankel, A. D., & Young, J. A. T. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.1 · Cited by 920
Emerging issues of connexin channels: biophysics fills the gap
L. Harris, A. (2001) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583501003705 · Cited by 800
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Self-citationStructural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
“…al., 1994), and NMR methods were used to determine the solution-state structures of the N-terminal zinc binding (Cai et al., 1997) and C-terminal DNA-binding domains (Eijkelenboom et al., 1995; Lodi et al., 1995; et al., 1996; Zheng et al., 1996), each of the isolated domains forms stable dimers.”
BackgroundMethodCrk family adaptors–signalling complex formation and biological roles
Feller, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204779 · Cited by 461
“The DNAbinding domain of the HIV-1 integrase has an SH3-like structure (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundStructural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Self-citationChen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404
Use of Chemical Shifts in Macromolecular Structure Determination
Wishart, D. S., & Case, D. A. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)38214-4 · Cited by 368
Solution structure of the N-terminal zinc binding domain of HIV-1 integrase
Cai, M., Zheng, R., Caffrey, M., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-567 · Cited by 342
Self-citationZheng, R., Jenkins, T. M., & Craigie, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13659 · Cited by 341
Self-citationCraigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
“The carboxy-terminal domain structure was also solved by NMR, revealing an SH3-like b barrel (Eijkelenboom et al. 1995; Lodi et al. 1995).”
BackgroundSelf-citationWang, J.-Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7333 · Cited by 335
“The solution structures of the isolated N- and C-terminal domains have also been determined by NMR (Eijkelenboom et al., 1995, 1997; Lodi et al., 1995; Cai et al., 1997).”
BackgroundMethodSelf-citationDetermining the structures of large proteins and protein complexes by NMR
Clore, G. M., & Gronenborn, A. M. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01135-9 · Cited by 274
Self-citationEsposito, D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5832 · Cited by 272
“The NMR structure of this domain reveals a dimer with an SH3-like fold, which produces a large cleft that has been proposed to bind DNA (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundSelf-citationA Soluble Active Mutant of HIV-1 Integrase
Jenkins, T. M., Engelman, A., Ghirlando, R., & Craigie, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7712 · Cited by 271
Self-citationIntegrating DNA: Transposases and Retroviral Integrases
Haren, L., Ton-Hoang, B., & Chandler, M. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.245 · Cited by 261
HIV Integrase, a Brief Overview from Chemistry to Therapeutics
Craigie, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100027200 · Cited by 258
Self-citationNMR spectroscopy: a multifaceted approach to macromolecular structure
Ferentz, A. E., & Wagner, G. (2000) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003589 · Cited by 239
“Although there have been cases in which identification of NOEs inconsistent with the rest of the structure was straightforward (Clore et al. 1989; Lodi et al. 1995), this is seldom trivial and experimental methods for explicitly identifying inter-monomer NOEs are generally the better choice.”
BackgroundIntegrase and integration: biochemical activities of HIV-1 integrase
Delelis, O., Carayon, K., Saïb, A., Deprez, E., & Mouscadet, J.-F. (2008) · Retrovirology · doi:10.1186/1742-4690-5-114 · Cited by 233
“However, several structures of isolated domains or of two consecutive domains have been reported [20-25].”
BackgroundRetroviral DNA integration: reaction pathway and critical intermediates
Li, M., Mizuuchi, M., Burke, T. R., & Craigie, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601005 · Cited by 233
“Structures of all three domains of HIV-1 integrase have been determined (Dyda et al, 1994; Lodi et al, 1995; Cai et al, 1997), as have several two-domain structures (Chen et al, 2000a; Wang et al, 2001).”
BackgroundSelf-citationLesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Self-citationJenkins, T. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6849 · Cited by 232
“The C-terminal domain has an SH3like fold that reveals a putative DNA-binding surface (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundSelf-citationHIV Integrase Structure and Function
Esposito, D., & Craigie, R. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60304-8 · Cited by 227
Self-citationNew methods of structure refinement for macromolecular structure determination by NMR
Clore, G. M., & Gronenborn, A. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5891 · Cited by 227
Self-citationRetroviral integrases and their cousins
Rice, P., Craigie, R., & Davies, D. R. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80098-4 · Cited by 211
Self-citationHindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
“Nuclear magnetic resonance spectroscopy (NMR) solution structural data is available for the HIV-1 IN N and C-terminal domains (11, 12, 21, 22, 65).”
BackgroundMethodInfluentialHIV-1 Integrase: Structural Organization, Conformational Changes, and Catalysis
Asante-Appiah, E., & Skalka, A. M. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60306-1 · Cited by 192
Basics of the virology of HIV-1 and its replication
Sierra, S., Kupfer, B., & Kaiser, R. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.09.004 · Cited by 185
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167
Hare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000259 · Cited by 166
“The CTD features an SH3-like fold, is rich in basic residues and is likely involved in DNA binding [11,12].”
BackgroundSelf-citationHuman cell proteins and human immunodeficiency virus DNA integration
Turlure, F. (2004) · Frontiers in Bioscience · doi:10.2741/1472 · Cited by 159
“The less conserved CTD (HIV-1 residues 213 to 288) forms an SH3-like fold (64, 65) that also contributes to IN multimerization (66, 67) and makes sequence-specific (68) and non-specific (67, 69-71) contacts with DNA (figure 2).”
BackgroundMolecular mechanisms in retrovirus DNA integration
Asante‐Appiah, E., & Skalka, A. M. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00046-6 · Cited by 172
Retroviral DNA Integration—Mechanism and Consequences
Lewinski, M. K., & Bushman, F. D. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)55005-3 · Cited by 257
Retroviral Integrase, Putting the Pieces Together
Andrake, M. D., & Skalka, A. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19633 · Cited by 134
Marchand, C., Johnson, A. A., Karki, R. G., Pais, G. C. G., Zhang, X., Cowansage, K., Patel, T. A., Nicklaus, M. C., Burke, T. R., & Pommier, Y. G. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.600 · Cited by 143
“Known crystal structures (Lodi et al., 1995; Cai et al., 1997; Maignan et al., 1998; Goldgur et al., 1999; Chen et al., 2000a; Wang et al., 2001) were used as templates for structure building.”
MethodFunctional and structural characterization of the integrase from the prototype foamy virus
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn938 · Cited by 130
Eijkelenboom, A. P. A. M., van den Ent, F. M. I., Vos, A., Doreleijers, J. F., Hård, K., Tullius, T. D., Plasterk, R. H. A., Kaptein, R., & Boelens, R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00332-0 · Cited by 137
“The solution structure of the carboxy-terminal DNA-binding domain as determined by nuclear magnetic resonance (NMR) has been reported to have a Src homology 3 (SH3)-like fold [15,16].”
Structure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Self-citationMcKee, C. J., Kessl, J. J., Shkriabai, N., Dar, M. J., Engelman, A., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805843200 · Cited by 152
Self-citationGao, K., Butler, S. L., & Bushman, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3565 · Cited by 137
Tsurutani, N., Kubo, M., Maeda, Y., Ohashi, T., Yamamoto, N., Kannagi, M., & Masuda, T. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4795-4806.2000 · Cited by 139
Lutzke, R. A. P., & Plasterk, R. H. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4841-4848.1998 · Cited by 132
“The three-dimensional structure of IN220–270 has been solved by NMR spectroscopy (18, 44), and the structure revealed that IN220–270 consists of five b strands which form two antiparallel b sheets (Fig.”
BackgroundMethodInfluentialYang, Z., Mueser, T. C., Bushman, F. D., & Hyde, C. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3463 · Cited by 127
Ramos, A., Hollingworth, D., Adinolfi, S., Castets, M., Kelly, G. P., Frenkiel, T. A., Bardoni, B., & Pastore, A. (2006) · Structure · doi:10.1016/j.str.2005.09.018 · Cited by 125
Structural biology of retroviral DNA integration
Li, X., Krishnan, L., Cherepanov, P., & Engelman, A. (2011) · Virology · doi:10.1016/j.virol.2010.12.008 · Cited by 126
“The HIV-1 CTD folds into a 5-stranded beta barrel that interestingly resembles a Src homology 3 (SH3) domain (Eijkelenboom et al., 1995; Eijkelenboom et al., 1999; Lodi et al., 1995) (Fig.”
BackgroundSelf-citationProtein intrinsic disorder as a flexible armor and a weapon of HIV-1
Xue, B., Mizianty, M. J., Kurgan, L., & Uversky, V. N. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0859-3 · Cited by 119
“Similar to the N-terminal domain, the C-terminal domain of HIV-1 integrase is a dimer in solution [246].”
BackgroundA supramolecular assembly mediates lentiviral DNA integration
Ballandras-Colas, A., Maskell, D. P., Serrao, E., Locke, J., Swuec, P., Jónsson, S. R., Kotecha, A., Cook, N. J., Pye, V. E., Taylor, I. A., et al. (2017) · Science · doi:10.1126/science.aah7002 · Cited by 107
Self-citationSvarovskaia, E. S., Barr, R., Zhang, X., Pais, G. C. G., Marchand, C., Pommier, Y. G., Burke, T. R., & Pathak, V. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3210-3222.2004 · Cited by 113
“The crystal and/or nuclear magnetic resonance structures of the three domains have been determined in various combinations, but the structure of the entire HIV-1 IN protein has not been determined (8, 15, 16, 25, 43, 66).”
BackgroundBujacz, G., Alexandratos, J., Zhou-Liu, Q., Clément-Mella, C., & Wlodawer, A. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01236-7 · Cited by 106
DNA binding to RecD: role of the 1B domain in SF1B helicase activity
Saikrishnan, K., Griffiths, S., Cook, N., Court, R., & Wigley, D. B. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.144 · Cited by 105
“Interestingly, the DNA-binding domain of HIV-1 integrase (Vink et al, 1993) has been shown to have an SH3-like fold (Eijkelenboom et al, 1995; Lodi et al, 1995 ).”
BackgroundA large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration
Wei, S., Mizuuchi, K., & Craigie, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7511 · Cited by 102
“The C-terminal domain binds DNA non-specifically (Vink et al., 1993; Woerner and MarcusSekura, 1993; Engelman et al., 1994), and the structure of this domain has been solved by NMR (Eijkelenboom et al., 1995; Lodi et al., 1995).”
BackgroundSelf-citationChen, Z., Yan, Y., Munshi, S. K., Li, Y., Zugay-Murphy, J., Xu, B., Witmer, M. V., Felock, P. J., Wolfe, A. L., Sardana, V. V., et al. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3451 · Cited by 106
Inhibiting the HIV Integration Process: Past, Present, and the Future
Santo, R. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400674a · Cited by 112
Mechanism of Inhibition of HIV-1 Integrase by G-tetrad-forming Oligonucleotides in Vitro
Jing, N., Marchand, C., Liu, J., Mitra, R., Hogan, M. E., & Pommier, Y. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001436200 · Cited by 101
Retroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0024-2014 · Cited by 94
“(D) The structure of the HIV-1 integrase CTD as determined by NMR (pdb code 1IHV) (142) highlights Arg231, which has been implicated in target DNA binding (108,”
BackgroundSelf-citationHIV-1 IN Inhibitors: 2010 Update and Perspectives
Marchand, C., Maddali, K., Métifiot, M., & Pommier, Y. G. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630910 · Cited by 96
In VitroAssays for Activities of Retroviral Integrase
Chow, S. A. (1997) · Methods · doi:10.1006/meth.1997.0484 · Cited by 96
Gerton, J. L., Ohgi, S., Olsen, M., DeRisi, J., & Brown, P. O. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5046-5055.1998 · Cited by 86
“Biochemical methods have demonstrated that this isolated domain exists as a dimer in solution (1, 46), and in the case of HIV-1 integrase, the solution structure has been solved as a dimer (24, 46).”
BackgroundLubkowski, J. T., Yang, F., Alexandratos, J. N., Wlodawer, A., Zhao, H., Burke, T. R., Neamati, N., Pommier, Y. G., Merkel, G. W., & Skalka, A. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4831 · Cited by 84
Masuda, T., Kuroda, M. J., & Harada, S. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8396-8402.1998 · Cited by 83
“In addition, both the N- and C-terminal regions are required for full IN activities in vitro (17, 52, 59).”
BackgroundPiecing together the structure of retroviral integrase, an important target in AIDS therapy
Jaskólski, M., Alexandratos, J. N., Bujacz, G., & Wlodawer, A. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07009.x · Cited by 97
“The structure of the isolated CTD of HIV-1 IN (residues 220-270, the carboxyl terminus truncated) was solved independently by two groups using NMR (1IHV; [80] and 1QMC; [78,81]).”
MethodA Metal-induced Conformational Change and Activation of HIV-1 Integrase
Asante‐Appiah, E., & Skalka, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16196 · Cited by 91
The Molecular Biology of HIV Integrase
Craigie, R. (2012) · Future Virology · doi:10.2217/fvl.12.56 · Cited by 108
Self-citationRefined solution structure of the c-terminal DNA-binding domain of human immunovirus-1 integrase
Eijkelenboom, A. P. A. M., Sprangers, R., H�rd, K., Puras Lutzke, R. A., Plasterk, R. H. A., Boelens, R., & Kaptein, R. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19990901)36:4<556::aid-prot18>3.0.co;2-6 · Cited by 80
Barreca, M. L., Lee, K. W., Chimirri, A., & Briggs, J. M. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74958-3 · Cited by 78
“…of the three separate domains have been solved by x-ray crystallography or NMR spectroscopy (Dyda et al., 1994; Bujacz et al., 1996; Maignan et al., 1998; Goldgur et al., 1998; Greenwald et al., 1999; Eijkelenboom et al., 1995; Eijkelenboom et al., 1999; Lodi et al., 1995; Cai et al., 1997; 1998).”
BackgroundLu, R., Ghory, H. Z., & Engelman, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10356-10368.2005 · Cited by 89
“Amino acid side chains were highlighted on the dimeric NMR structure (Protein Data Bank entry 1IHV) (56) using the following coloring scheme: Val-234, red; Glu-246, orange; Lys-258, yellow; Arg-262, magenta; Lys-264, pink.”
BackgroundMethodInfluentialSelf-citationStructures of Protein Complexes by Multidimensional Heteronuclear Magnetic Resonance Spectroscopy
Gronenborn, A. M., & Clore, G. M. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083489 · Cited by 85
“…M13 (Folkers et al., 1994); the chemokines hMIP-1P (Lodi et al., 1994), GRO/MGSA (Fairbrother et al., 1994; Kim et al., 1994), RANTES (Skelton et al., 1995), the Mnt repressor (Burgering et al., 1994), and the DNA-binding domain of HIV-1 integrase (Lodi et al., 1995, and Eijkelenboom et al., 1995).”
BackgroundSelf-citationMode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
Cherepanov, P., Esté, J. A., Rando, R. F., Ojwang, J. O., Reekmans, G., Steinfeld, R., David, G., Clercq, E. D., & Debyser, Z. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.771 · Cited by 77
“NMR structures of a truncated carboxyl-terminal domain have been determined (10, 11).”
Biomedicine and Diseases: Review¶Assembling the human immunodeficiency virus type 1
Cimarelli, A., & Darlix, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8495-6 · Cited by 113
Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection
hio Shibagaki, Y., & Chow, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8361 · Cited by 73
HIV-1 Integrase as a Target for Antiviral Drugs
Pommier, Y. G., Pilon, A. A., Bajaj, K., Mazumder, A., & Neamati, N. (1997) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029700800601 · Cited by 74
Molecular Dynamics Studies on the HIV-1 Integrase Catalytic Domain
Lins, R. D., Briggs, J. M., Straatsma, T. P., Carlson, H. A., Greenwald, J., Choe, S., & McCammon, J. A. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77453-9 · Cited by 72
“The C-terminal domain, residues ;212–288, takes on an SH3type fold (Lodi et al., 1995; Lutzke and Plasterk, 1998; Eijkelenboom et al., 1995) and is known to bind DNA strongly but nonspecifically (Lutzke and Plasterk, 1998; Khan et al.”
BackgroundIdentifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase
Wilkinson, T. A., Januszyk, K., Phillips, M. L., Tekeste, S. S., Zhang, M., Miller, J. T., Grice, S. F. J. L., Clubb, R., & Chow, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806241200 · Cited by 75
Serrao, E., Krishnan, L., Shun, M.-C., Li, X., Cherepanov, P., Engelman, A., & Maertens, G. N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku136 · Cited by 59
Self-citationThe Impact of HIV-1 Drug Escape on the Global Treatment Landscape
Collier, D. A., Monit, C., & Gupta, R. K. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.06.010 · Cited by 68
Modeling HIV‐1 integrase complexes based on their hydrodynamic properties
Podtelezhnikov, A. A., Gao, K., Bushman, F. D., & McCammon, J. A. (2002) · Biopolymers · doi:10.1002/bip.10217 · Cited by 72
Nakagawa, A., Nakashima, T., Taniguchi, M., Hosaka, H., Kimura, M., & Tanaka, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1459 · Cited by 64
“These are N-terminal domain of the proto-oncogene product c-Crk (Wu et al., 1995) and the DNA-binding domain of HIV-1 integrase (Lodi et al., 1995).”
BackgroundAllosteric Inhibitor Development Targeting HIV‐1 Integrase
Al‐Mawsawi, L. Q., & Neamati, N. (2011) · ChemMedChem · doi:10.1002/cmdc.201000443 · Cited by 67
Barreca, M. L., Iraci, N., Luca, L. D., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900166 · Cited by 70
Christensen, A. M., Massiah, M. A., Turner, B. G., Sundquist, W. I., & Summers, M. F. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0700 · Cited by 59
Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)
Larue, R., Gupta, K., Wuensch, C., Shkriabai, N., Kessl, J. J., Danhart, E., Feng, L., Taltynov, O., Christ, F., Van Duyne, G. D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384669 · Cited by 59
Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
Zhao, L., O’Reilly, M. K., Shultz, M. D., & Chmielewski, J. A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00040-4 · Cited by 58
Ikeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M., & Masuda, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11563-11573.2004 · Cited by 71
“These studies of HIV-1 IN identified three functional domains: an N-terminal zinc binding domain (6–8), a central catalytic core domain (7, 11, 18, 57, 63), and a Cterminal nonspecific DNA binding domain (11, 19, 46).”
Kumar, V., & Kannan, K. K. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1491 · Cited by 64
Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design
Karki, R. G., Tang, Y., Burke, T. R., & Nicklaus, M. C. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-0365-5 · Cited by 64
Craigie, R. (2007) · Mobile DNA II · doi:10.1128/9781555817954.ch25 · Cited by 58
Self-citationQuinoline-based HIV Integrase Inhibitors
Musioł, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319100008 · Cited by 61
Engelman, A., & Cherepanov, P. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.005 · Cited by 61
“The CTD-CTD dimerization interface originally discovered via nuclear magnetic resonance spectroscopy is another previously underappreciated HIV-1 IN structure that is observed in the higher-order lentiviral intasome structures, but absent in the tetrameric Sso7d-IN intasome [7 ,21 ,33,34].”
BackgroundSelf-citationSubcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases
Kukolj, G., Jones, K. S., & Skalka, A. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.843-847.1997 · Cited by 57
Jing, N., Clercq, E. D., Rando, R. F., Pallansch, L. A., Lackman-Smith, C., Lee, S., & Hogan, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3421 · Cited by 57
Sourgen, F., Maroun, R. G., Frère, V., Bouziane, M., Auclair, C., Troalen, F., & Fermandjian, S. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0765h.x · Cited by 57
Romir, J., Lilie, H., Egerer-Sieber, C., Bauer, F., Sticht, H., & Muller, Y. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.058 · Cited by 54
Yao, M. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg011 · Cited by 54
A Three-dimensional Model of the Human Immunodeficiency Virus Type 1 Integration Complex
Wielens, J., Crosby, I. T., & Chalmers, D. K. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-5256-2 · Cited by 64
Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking
Luca, L. D., Pedretti, A., Vistoli, G., Barreca, M. L., Villa, L., Monforte, P., & Chimirri, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.120 · Cited by 56
Blanco, F. J., Ortíz, Á. R., & Serrano, L. G. (1997) · Journal of Biomolecular NMR · doi:10.1023/a:1018330122908 · Cited by 54
“Recently, the SH3 fold has also been found in protein domains involved in a wider range of functions as DNA binding and electron transport (Falzone et al., 1994; Lodi et al., 1995, and references cited therein).”
BackgroundRaltegravir: molecular basis of its mechanism of action
Mouscadet, J. F., & Tchertanov, L. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s3-5 · Cited by 70
“It consists of two symmetric monomers of five antiparallel β-strands, which form a β-barrel and adopt an SH3-like fold [30, 63].”
BackgroundKessl, J. J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J. O., Feng, L., Musier-Forsyth, K., Craigie, R., & Kvaratskhelia, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr581 · Cited by 52
Self-citationBinding Aspects of Baicalein to HIV-1 Integrase
Ahn, H., Lee, S.-Y., Kim, J., Son, W.-S., Shin, C., & Lee, B. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17072-5 · Cited by 52
Structural Determinants of Metal-induced Conformational Changes in HIV-1 Integrase
Asante‐Appiah, E., Seeholzer, S. H., & Skalka, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35078 · Cited by 52
Metadata
- Authors
- Lodi, P. J., Ernst, J. A., Kuszewski, J., Hickman, A. B., Engelman, A., Craigie, R., Clore, G. M., & Gronenborn, A. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-08-08
- Volume
- 34
- Issue
- 31
- Pages
- 9826-9833
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2140854337
- Cited by
- 300
- References
- 41
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 integrase, DNA-binding domain, solution structure, protein dimer, DNA binding sites, lysine residues, antiparallel beta-sheet
- MeSH terms
- Amino Acid Sequence, Binding Sites, DNA Nucleotidyltransferases, DNA-Binding Proteins, Escherichia coli, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Peptide Fragments, Protein Conformation, Proteins, Recombinant Proteins, Solutions, Spectrin, HIV-1, Sequence Homology, Integrases, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.